We use some essential cookies to make this website work.
We’d like to set additional cookies to understand how you use GOV.UK, remember your settings and improve government services.
We also use cookies set by other sites to help us deliver content from their services.
You have accepted additional cookies. You can change your cookie settings at any time.
You have rejected additional cookies. You can change your cookie settings at any time.
Departments, agencies and public bodies
News stories, speeches, letters and notices
Detailed guidance, regulations and rules
Reports, analysis and official statistics
Consultations and strategy
Data, Freedom of Information releases and corporate reports
Patients in the UK and Singapore could gain faster access to cutting-edge healthcare innovations under a new partnership bringing two globally respected regulators together with one of the world’s leading biotech creators.
Professor Anthony Harnden has congratulated the trio of Agency board members on the extension of their appointments.
As with any medicine, the MHRA will keep the safety and effectiveness of mirdametinib under close review.
Forensic Science Regulator newsletters cover issues of interest and relevance to forensic science practitioners.
The MHRA and Northern Ireland partners are working together to support innovation, enhance patient safety and ensure people in Northern Ireland benefit from world-class regulation.
All babies in the UK get the hepatitis B vaccine. It has a well-established safety record and ensures long-term protection against the virus.
A story of hope, medical innovation, and the impact of effective regulation on access to treatment.
As with all licensed medicines, we will continue to monitor its safety closely as it becomes more widely used
The MHRA has five top tips to help you stay well through the festive season and beyond
An Expert Working Group has completed a review into how the potential risks associated with antidepressant medicines are communicated to patients
Study provides crucial insights for targeting rapid response strategies and improving polio surveillance worldwide
Additional funding will allow the MHRA and NICE to continue developing clear, proportionate guidance for digital mental health technologies, supporting safer, more effective tools for people across the UK.
The MHRA has today, 26 November 2025, approved inavolisib (Itovebi) for the treatment of adults with a type of breast cancer called HR-positive
Vaccination is one of the most effective and safest ways to protect against many serious infectious diseases
New government funding will help make the boldest ideas in UK life sciences a reality.
International collaboration establishes new quality standards to improve reliability of gut health studies – improving accuracy to provide better diagnosis and treatment.
As part of #MedSafetyWeek, the MHRA’s Chief Safety Officer reflects in The Pharmacist on the vital role pharmacists play in keeping medicines and medical devices safe.
The Medicines and Healthcare products Regulatory Agency (MHRA) has approved Siiltibcy
Professor Jacob George has been appointed as the first Chief Medical and Scientific Officer for the Medicines and Healthcare products Regulatory Agency (MHRA).…
Professor Henrietta Hughes reflects on how MHRA strategy must prioritise patient safety via listening to lived experiences, fostering collaboration & innovation.
Don’t include personal or financial information like your National Insurance number or credit card details.
To help us improve GOV.UK, we’d like to know more about your visit today. Please fill in this survey (opens in a new tab and requires JavaScript).